The Role of Cost-Effectiveness Analysis in Patient-Centered Cancer Care in the Era of Precision Medicine
Over the last few decades, changes in diagnostic and treatment paradigms have greatly advanced cancer care and improved outcomes [...]
Main Authors: | Fabrizio Toscano, Alberto Vera, Eleanor Kim, Davide Golinelli, Helena Vila-Reyes, Fernand Bteich, Antoine Schernberg, Romain-David Seban, Randy Yeh, Laurent Dercle |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/17/4272 |
Similar Items
-
Editorial: Breakthrough in Imaging-Guided Precision Medicine in Oncology
by: Ashley Shaw, et al.
Published: (2022-05-01) -
The Role of 18F-FDG PET/CT in Guiding Precision Medicine for Invasive Bladder Carcinoma
by: Antoine Girard, et al.
Published: (2020-10-01) -
Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy
by: Romain-David Seban, et al.
Published: (2019-05-01) -
Advances in PET/CT Imaging for Breast Cancer Patients and Beyond
by: David Khalil, et al.
Published: (2023-01-01) -
Precision Medicine: The new era in medicine
by: Marinka Twilt
Published: (2016-02-01)